Quick answer: Wegovy and Ozempic are two brand names for the same active ingredient (semaglutide), but they're approved for different uses. Ozempic is approved to improve blood sugar control in adults with type 2 diabetes, while Wegovy is specifically approved for chronic weight management in adults and adolescents with obesity or overweight with weight-related conditions. Wegovy uses a higher maximum dose than Ozempic. Both require a prescription and medical supervision, and both are only safe when sourced from legitimate pharmacies — the sharp rise in demand has led to counterfeit and compounded versions that carry real risks.
Same molecule, different purpose
Both Wegovy and Ozempic are made by Novo Nordisk, and both contain semaglutide — a GLP-1 receptor agonist that mimics a natural hormone regulating blood sugar and appetite. The molecule is the same. What changes is the approved use, the dosing, and how each was studied and labeled by regulators.
Considering one of these medications?
Our internal medicine and endocrinology specialists evaluate whether it's appropriate for you before prescribing.
Key differences at a glance
| Ozempic | Wegovy | |
| Active ingredient | Semaglutide | Semaglutide |
| Approved use | Type 2 diabetes; cardiovascular risk reduction in T2D with heart disease | Chronic weight management in adults and adolescents ≥12 with obesity |
| Maximum dose | 2.0 mg once weekly | 2.4 mg once weekly |
| Dose escalation | Gradual over months | Gradual over months |
| Administration | Weekly subcutaneous injection | Weekly subcutaneous injection |
| Weight loss | Common as a secondary effect | Primary intended effect |
| Availability in Mexico | Widely available with prescription | May vary — confirm current availability with your doctor |
When is Ozempic the right choice?
- You have type 2 diabetes and need better blood sugar control alongside diet and exercise
- You have type 2 diabetes and established heart disease — Ozempic has been shown to reduce cardiovascular events
- Your doctor has determined that a GLP-1 medication fits your overall diabetes management plan
Ozempic is not approved for type 1 diabetes.
When is Wegovy the right choice?
- Adults with a BMI of 30 or higher (obesity)
- Adults with a BMI of 27-29.9 (overweight) plus at least one weight-related condition (high blood pressure, high cholesterol, type 2 diabetes)
- Adolescents 12 and older with obesity, in specific clinical situations
Wegovy is meant to be part of a comprehensive weight management program — not a substitute for nutrition, physical activity, or medical supervision.
What are the common side effects?
Because both are semaglutide, they share the same side effect profile:
- Nausea, especially at the start of treatment or with dose increases
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Fatigue
These usually improve as your body adjusts to the medication. Wegovy's higher maximum dose can mean slightly more prominent side effects at peak dosing.
Serious side effects to watch for
Contact your doctor right away if you experience:
- Lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath (possible thyroid issue)
- Severe, persistent abdominal pain (possible pancreatitis)
- Mood changes or thoughts of self-harm
- Signs of gallbladder problems — pain in the upper right abdomen, fever, yellowing of the skin or eyes
- Kidney problems, especially with severe nausea, vomiting, or dehydration
Neither medication should be used if you or a family member has a history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2).
Warning: counterfeits and compounded versions
The surge in demand for semaglutide has created a real risk of counterfeit products, unregulated compounded versions, and online purchases without medical supervision. This matters because:
- Counterfeit pens may contain no active ingredient, an incorrect dose, or dangerous substances
- Compounded semaglutide is not the same as FDA/COFEPRIS-approved Wegovy or Ozempic and has been linked to serious adverse events
- Improper storage (semaglutide requires refrigeration) can render even authentic medication ineffective or unsafe
- Without a doctor's follow-up, you miss the safety monitoring that these medications require
If you're considering Wegovy or Ozempic, only obtain them through a licensed physician and a legitimate pharmacy. At Hospital CMQ, our hospital pharmacy sources these medications directly, with proper cold-chain storage from manufacturer to patient.
Who should not use Wegovy or Ozempic?
- People with personal or family history of medullary thyroid cancer or MEN2
- People with a history of severe pancreatitis
- Pregnant or planning to become pregnant — talk with your doctor before starting
- Breastfeeding — safety is not fully established
- Type 1 diabetes (Ozempic is not approved for this)
- Severe gastrointestinal disease without medical evaluation first
Integrated care under one roof
Whether you're being evaluated for type 2 diabetes management or weight loss, having every service in the same hospital makes the process safer and simpler:
- Consultation with internal medicine or endocrinology to determine if semaglutide is right for you
- Lab work (glucose, HbA1c, lipid panel, kidney function, thyroid) at our in-house lab
- Nutrition consultation to build the eating plan that goes with the medication
- Cardiology consultation for cardiovascular risk assessment
- Bariatric surgery consultation if it's a better fit for your case
- In-hospital pharmacy with authentic Wegovy and Ozempic, stored under proper refrigeration
- Follow-up appointments with the same specialist every 3 months, with your history already on file
- Bilingual staff and direct billing with US and Canadian insurance
Responsible medical evaluation at Hospital CMQ
Wegovy and Ozempic can be effective tools for the right patient, but they're not shortcuts. A proper medical evaluation confirms whether either medication fits your case and monitors for side effects.
Our team is available at all three of our hospitals across Banderas Bay:
- Hospital CMQ City Center — Malecón / Romantic Zone: (322) 223 1919
- Hospital CMQ Premiere — Marina Vallarta / Main Hotel Zone: (322) 226 6500
- Hospital CMQ Riviera Nayarit — Bucerías / Nuevo Vallarta: (329) 298 0717
Book your consultation via WhatsApp at +52 322 147 0044. English-speaking staff available.
The information provided in this article is for educational purposes only and should not be used as a substitute for professional medical advice.
Reading time: 7 minutes
References
- FDA — Prescribing information for Ozempic (semaglutide).
- FDA — Prescribing information for Wegovy (semaglutide).
- Novo Nordisk — Product information.
- FDA — Warnings about compounded semaglutide.
